The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Early Detection of Breast Cancer and Cervical Cancer in Women in India
Official Title: Early Detection of Common Cancers in Women in India
Study ID: NCT00632047
Brief Summary: RATIONALE: Health education programs and screening methods, such as clinical breast examination and examination of the cervix, may help reduce the number of women who develop breast cancer and cervical cancer. PURPOSE: This randomized clinical trial is studying the early detection of breast cancer and cervical cancer in women in India.
Detailed Description: OBJECTIVES: * To investigate the effectiveness of well planned health education programs (HEP) and low-cost screening methods (e.g., clinical breast examination \[CBE\] and visual inspection of the cervix painted with 4% acetic acid \[VIA\]) in down-staging and reducing the incidence of and mortality due to breast and cervical cancer. OUTLINE: Patients are randomized to 1 of 2 arms. * Arm I (intervention): Participants undergo intervention comprising health education programs (HEP), clinical breast examination (CBE), and visual inspection of the cervix painted with 4% acetic acid (VIA) every 2 years for up to 8 years. Participants also undergo active surveillance over 8 years. * Arm II (control): Participants receive one HEP. Participants also undergo active surveillance over 8 years.
Minimum Age: 35 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Tata Memorial Hospital, Mumbai, , India
Name: Surendra S. Shastri, MD
Affiliation: Tata Memorial Hospital
Role: PRINCIPAL_INVESTIGATOR